Thursday, September 14, 2006
FDA Whistleblower Blasts New Merck Painkiller
Dr. David Graham, whistleblower working within the confines of the FDA’s struggling drug safety offices, continues his public attack on the lack of safety condoned by the FDA. Graham believes that Merck’s new arthritis drug, Arcoxia, like Vioxx, poses undue cardiovascular risk. Writing on the Journal of the American Medical Association’s website he states, “The FDA, academia, and the medical research enterprise are once again faced with the opportunity to forsake common sense by willfully accepting misdirection and disinformation presented in the guise of science.” Big Pharma operates like a profit-mongering form of cancer, not only buying every phase of the drug development and regulation process, but paying off Capital Hill as well.
